Phase 1/2 Study of ABI-009 in Nonmuscle Invasive Bladder Cancer

Non-muscle Invasive Bladder Cancer (NMIBC) Clinical Trial

Official title:
A Combined Phase 1 and Phase 2 Study of Albumin-bound Rapamycin Nanoparticles (Nab-rapamycin, ABI-009) in the Treatment of BCG Refractory or Recurrent Nonmuscle Invasive Transitional Cell Bladder Cancer

Status Completed

Clinical Trial Summary

Purpose of this study is to determine appropriate dosing of ABI-009 and evaluate the safety and anti-tumor activity of ABI-009 in treatment of non-muscle invasive bladder cancer

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Non-muscle Invasive Bladder Cancer (NMIBC)
Urinary Bladder Neoplasms

Clinical Trial Details

NCT number	NCT02009332
Study type	Interventional
Source	Aadi, LLC
Contact
Status	Completed
Phase	Phase 1/Phase 2
Start date	April 9, 2014
Completion date	December 1, 2019

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT03839472` - Continuous Bladder Irrigation Following Transurethral Resection of Bladder Tumors	N/A
Completed	`NCT03672240` - Study of APL-1202 in Non-Muscle Invasive Bladder Cancer Patients Who Are Resistant to One Induction Course of BCG Treatment	Phase 1/Phase 2
Recruiting	`NCT04179162` - Bacillus Calmette-Guérin (BCG) and Gemcitabine in People With High-Grade Non-Muscle Invasive Bladder Cancer That Came Back After BCG Treatment	Phase 1/Phase 2
Terminated	`NCT03719300` - Codex: Study of Inodiftagene Vixteplasmid (BC-819) in Unresponsive NMIBC	Phase 2
Terminated	`NCT03167151` - Pembrolizumab in Intermediate Risk Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)	Phase 1/Phase 2
Recruiting	`NCT03148158` - Assessment Of Bladder Tumors Stage And Grade By Outpatient Flexible Cystoscopy Performed By Urology Resident	N/A
Terminated	`NCT06069453` - Hyaluronic Acid Sodium Salt and Hydeal-D in the Management of LUTS After TURBT for NMIBC.	N/A
Recruiting	`NCT05176145` - Demonstration of the Medical Interest of the VisioCyt® Artificial Intelligence Test	N/A